mardi 23 avril 2013

LinkedIn Network Updates, 4/24/2013

 
 
 
LinkedIn
Network Updates, Apr 17 - Apr 24
 
LinkedIn
 
 
 
Updates from Your Extended Network
Connect with them to see what they're up to
 
 
Matt Boeckeler
 
Matt Boeckeler http://lnkd.in/uFy4xt
 
 
AstraZeneca follows Pfizer for BIND's second cancer nano-drug deal of...
 
AstraZeneca follows Pfizer for BIND's second cancer nano-drug deal of...
 
AstraZeneca is set to pay up to $199 million to Cambrige biotech BIND Therapeutics for development of Accurin, a cancer nanomedicine based on a kinase inhibitor owned by AstraZeneca (NYSE: AZN).
 
 
 
 
Cheryl Winter, MS RD, MS APRN, CDE, BC-ADM, FNP
 
Cheryl Winter, MS RD, MS APRN, CDE, BC-ADM, FNP Do you sneak #healthy foods like vegetables into your child's foods? http://ow.ly/kkamr
 
 
 
 
 
Charles Kirk
 
Charles Kirk http://lnkd.in/cWhSaU
 
 
The 10 Books Guaranteed To Chage Your Mindset and Move You Forward
 
The 10 Books Guaranteed To Chage Your Mindset and Move You Forward
 
Have you ever read a book that completely changed your thinking and actions moving forward?  Has a book been so powerful that you continue to implement it’s principles to this day?  Some books stick but most books admittedly don’t. I’ve read and...
 
 
 
 
Stephanie Andrzejewski
 
Stephanie Andrzejewski Interesting depiction of the pharmaceutical industry's pipeline. Not surprising oncology is big. http://lnkd.in/kUMC6Y
 
 
Industry Atlas - Forbes
 
Industry Atlas - Forbes
 
A look at some of the hottest topics in six critical industries.
 
 
 
 
 
 
 
You are receiving Network Updates emails. Unsubscribe.
 
This email was intended for start292 almar (aasdfsdfsd at AstraZeneca). Learn why we included this. © 2013, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA
 

Aucun commentaire:

Enregistrer un commentaire